117 related articles for article (PubMed ID: 11475845)
1. [Serine protease inhibitors in plasma of patients with ulcerative colitis].
Swiatkowski M; Pulkowski G; Kłopocka M; Budzyński J; Wiśniewsk E; Kotschy M
Przegl Lek; 2001; 58(2):67-70. PubMed ID: 11475845
[TBL] [Abstract][Full Text] [Related]
2. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
[TBL] [Abstract][Full Text] [Related]
3. [Plasma serine protease inhibitors in dialyzed patients with chronic renal insufficiency].
Kotschy M; Kassian J; Lampka M; Rajewski W
Pol Merkur Lekarski; 1997 Feb; 2(8):93-5. PubMed ID: 9538647
[TBL] [Abstract][Full Text] [Related]
4. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D
Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267
[TBL] [Abstract][Full Text] [Related]
5. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
Marlar RA; Kressin DC; Madden RM
Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
[TBL] [Abstract][Full Text] [Related]
6. [Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].
Hainaut J; Dhennin C; Guilbaud J
Nouv Rev Fr Hematol (1978); 1982; 24(6):375-81. PubMed ID: 6188103
[TBL] [Abstract][Full Text] [Related]
7. Alpha 2-macroglobulin in patients with inflammatory bowel disease.
Brown DJ; Khan JA; Copeland G; Jewell DP
J Clin Lab Immunol; 1980 Jul; 4(1):53-7. PubMed ID: 6162029
[TBL] [Abstract][Full Text] [Related]
8. [Detection of the degree of activity of ulcerative colitis. Behavior of serum alpha 1-proteinase inhibitor and alpha 2-macroglobulin].
Amiguet JA; Sagüés J; Muñoz MA; Zozaya J; Conchillo F
Rev Esp Enferm Apar Dig; 1989 Apr; 75(4):345-7. PubMed ID: 2472652
[TBL] [Abstract][Full Text] [Related]
9. [Antithrombin III and alpha 2-antiplasmin in blood of patients operated on for benign prostatic hyperplasia].
Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):75-6. PubMed ID: 8756735
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
11. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
[TBL] [Abstract][Full Text] [Related]
12. [Plasma serine protease inhibitors in patients with liver cirrhosis].
Piatkowska M; Kotschy M; Rość D; Wiśniewska E; Opoka J
Acta Haematol Pol; 1994; 25(2):145-9. PubMed ID: 8067185
[TBL] [Abstract][Full Text] [Related]
13. High plasma osteopontin levels in patients with inflammatory bowel disease.
Mishima R; Takeshima F; Sawai T; Ohba K; Ohnita K; Isomoto H; Omagari K; Mizuta Y; Ozono Y; Kohno S
J Clin Gastroenterol; 2007 Feb; 41(2):167-72. PubMed ID: 17245215
[TBL] [Abstract][Full Text] [Related]
14. The functional role of acute phase plasma proteinase inhibitors.
Travis J; Shieh BH; Potempa J
Tokai J Exp Clin Med; 1988 Dec; 13(6):313-20. PubMed ID: 3152555
[TBL] [Abstract][Full Text] [Related]
15. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen: an important hemostatic parameter in septic patients.
Duboscq C; Quintana I; Bassilotta E; Bergonzelli GE; Porterie P; Sassetti B; Haedo AS; Wainsztein N; Kruithof EK; Kordich L
Thromb Haemost; 1997 Jun; 77(6):1090-5. PubMed ID: 9241738
[TBL] [Abstract][Full Text] [Related]
17. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
Annaházi A; Gecse K; Dabek M; Ait-Belgnaoui A; Rosztóczy A; Róka R; Molnár T; Theodorou V; Wittmann T; Bueno L; Eutamene H
Pain; 2009 Jul; 144(1-2):209-17. PubMed ID: 19450926
[TBL] [Abstract][Full Text] [Related]
18. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study.
Pamuk GE; Vural O; Turgut B; Demir M; Umit H; Tezel A
Am J Hematol; 2006 Oct; 81(10):753-9. PubMed ID: 16941615
[TBL] [Abstract][Full Text] [Related]
19. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.
Yüksel O; Helvaci K; Başar O; Köklü S; Caner S; Helvaci N; Abayli E; Altiparmak E
Platelets; 2009 Jun; 20(4):277-81. PubMed ID: 19459134
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease.
Bohe M; Genell S; Ohlsson K
Scand J Gastroenterol; 1986 Jun; 21(5):598-604. PubMed ID: 2428096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
